Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
Funding Opportunity RFA-MH-22-170 from the NIH Guide for Grants and Contracts. Efforts are underway to develop a safe and effective vaccine to protect people from acquiring HIV ultimately reducing the number of new infections and ending the epidemic. However, the subject of vaccines remains contentious, and COVID-19 has heightened the conversation. There are multiple messages circulating both for and against vaccines and a growing number of skeptics appear to be making decisions about vaccines based on misinformation. This initiative will advance research on communication factors and strategies that will be crucial for ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 3, 2022 Category: Research Source Type: funding
HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-22-045 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) to develop new, exploratory methods, approaches, and/or tools to apply to existing data streams (e.g., electronic health records, syndromic surveillance, claims data, registry data, pharmacy dispensing, and mortality records) that could provide novel insights into the dynamics of opioid and prescription drugs misuse, addiction, recovery, relapse, and recovery to facilitate rapid understanding of the opioid epidemic for prevention and treatment or to develop methods for small area esti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2021 Category: Research Source Type: funding
HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-22-044 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects focusing on developing new methods and approaches to obtain, extract or aggregate data from existing data streams (e.g., EHR, claims data, registry data, pharmacy dispensing, and mortality records) that can provide novel insights into the dynamics of opioids misuse, addiction, recovery, relapse and recovery and facilitate rapid understanding of the opioid epidemic to inform preventive and treatment interventions. It will emphasize approaches that shorte...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)
Notice NOT-HL-23-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2021 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College
Notice NOT-AA-22-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 9, 2021 Category: Research Source Type: funding
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This FOA solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 23, 2021 Category: Research Source Type: funding
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Technologies proposed for development may be inte...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 23, 2021 Category: Research Source Type: funding
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2021 Category: Research Source Type: funding
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. This FOA solicits R33 applications where major feasibility gaps for the technolog...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 3, 2021 Category: Research Source Type: funding
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Funding Opportunity PAR-21-341 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 12, 2021 Category: Research Source Type: funding
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
Funding Opportunity PAR-22-025 from the NIH Guide for Grants and Contracts. The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants designed to advance the diagnosis, prevention, treatment, and amelioration of human communication disorders. For this announcement, Clinical Research is defined as research involving individuals with communication disorders or data/tissues from individuals with a communication disorder. Examples of such research include but are not limited to, studies of the prevention, pathogenesis, pathophysiology, diagnosis, tr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 7, 2021 Category: Research Source Type: funding
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
Funding Opportunity PAR-21-348 from the NIH Guide for Grants and Contracts. The role of EBV infection on Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection and AIDS will increase our understanding through mechanistic, epidemiological, or translational studies that examine how EBV promotes NHL or HD initiation, progression and the resulting disease sequelae. In addition, insights into mechanistic differences of EBV infection and lymphomagenesis between HIV positive and HIV negative persons will be gained. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 27, 2021 Category: Research Source Type: funding
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Funding Opportunity PAR-22-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support pilot, feasibility or exploratory research in 5 priority areas in substance use epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to look into a large and sudden spike in opioid or synthetic cannabinoid use/overdoses in a particular community); 2) responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and time-sensitive prescription drug abuse research opportu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 2, 2021 Category: Research Source Type: funding
HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
Funding Opportunity RFA-NS-22-016 from the NIH Guide for Grants and Contracts. More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in the prescription of opioids for chronic pain despite their poor ability to improve function and high addiction liability. This contributed to a significant and alarming epidemic of opioid overdose deaths and addictions. Innovative scientific solutions to develop alternative pain treatment options are thus critically needed. Through targeted research...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2021 Category: Research Source Type: funding
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-503 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement. EDIC is an observational study that was launched at the completion of the Diabetes Control and Complications Trial (DCCT) trial. The DCCT showed that intensive therapy significantly reduced the risk of diabetes complications compared to conventional therapy. At DCCT completion, all cohort members were taught intensive diabetes therapy. In 1...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 17, 2021 Category: Research Source Type: funding
